Related Experiment Video
Updated: Apr 21, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells
Joseph Mazar1, Wei Zhao1, Ahmad M Khalil2
1Sanford-Burnham Medical Research Institute, Orlando, FL 32827, USA.
Abstract:
Expression of the long noncoding RNA (lncRNA) SPRY4-IT1 is low in normal human melanocytes but high in melanoma cells. siRNA knockdown of SPRY4-IT1 blocks melanoma cell invasion and proliferation, and increases apoptosis. To investigate its function further, we affinity purified SPRY4-IT1 from melanoma cells and used mass spectrometry to identify the protein lipin 2, an enzyme that converts phosphatidate to diacylglycerol (DAG), as a major binding partner. SPRY4-IT1 knockdown increases the accumulation of lipin2 protein and upregulate the expression of diacylglycerol O-acyltransferase 2 (DGAT2) an enzyme involved in the conversion of DAG to triacylglycerol (TAG). When SPRY4-IT1 knockdown and control melanoma cells were subjected to shotgun lipidomics, an MS-based assay that permits the quantification of changes in the cellular lipid profile, we found that SPRY4-IT1 knockdown induced significant changes in a number of lipid species, including increased acyl carnitine, fatty acyl chains, and triacylglycerol (TAG). Together, these results suggest the possibility that SPRY4-IT1 knockdown may induce apoptosis via lipin 2-mediated alterations in lipid metabolism leading to cellular lipotoxicity.
Insights
The long noncoding RNA SPRY4-IT1 is highly expressed in melanoma. Knocking down SPRY4-IT1 triggers apoptosis by altering lipid metabolism through its interaction with lipin 2.
Area of Science:
- Molecular biology
- Cancer research
- Lipidomics
Background:
- The long noncoding RNA (lncRNA) SPRY4-IT1 shows low expression in normal melanocytes but is upregulated in melanoma.
- SPRY4-IT1 knockdown inhibits melanoma cell invasion and proliferation while promoting apoptosis.
Purpose of the Study:
- To investigate the functional role of SPRY4-IT1 in melanoma.
- To identify proteins interacting with SPRY4-IT1.
- To elucidate the molecular mechanisms underlying SPRY4-IT1's effect on melanoma cell behavior.
Main Methods:
- Affinity purification of SPRY4-IT1 from melanoma cells.
- Mass spectrometry to identify binding partners.
- siRNA knockdown of SPRY4-IT1.
- Shotgun lipidomics to analyze cellular lipid profiles.
- Western blotting to assess protein levels.
Main Results:
- Lipin 2 was identified as a key binding partner of SPRY4-IT1.
- SPRY4-IT1 knockdown led to increased lipin 2 protein accumulation and upregulated DGAT2 expression.
- Lipidomic analysis revealed significant changes in lipid species, including increased acyl carnitine, fatty acyl chains, and triacylglycerol (TAG) upon SPRY4-IT1 knockdown.
- SPRY4-IT1 knockdown induced significant alterations in cellular lipid profiles.
Conclusions:
- SPRY4-IT1 interacts with lipin 2, influencing lipid metabolism in melanoma cells.
- Knockdown of SPRY4-IT1 induces changes in lipid metabolism, potentially leading to lipotoxicity and apoptosis.
- These findings suggest SPRY4-IT1 as a potential therapeutic target in melanoma treatment.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
Related Concept Videos
Non-LTR Retrotransposons
lncRNA - Long Non-coding RNAs
RNA Splicing
MicroRNAs
MicroRNAs
Chromatin Structure and RNA Splicing